Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2023-08-04
Original market date: See footnote 1
2023-08-04
Product name:
CLEVIPREX
Description:
FOR IV INFUSION ONLY. 50ML & 100ML SINGLE USE VIALS. PRESERVATIVE FREE.
DIN:
02366223
Product Monograph/Veterinary Labelling:
Date:
2022-06-22
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
CHIESI FARMACEUTICI S.P.A.
26/A Via Palermo
Parma
--
Italy
43122
Class:
Human
Dosage form(s):
Emulsion
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
24:28.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
C08CA16 CLEVIDIPINE
Active ingredient group (AIG) number:See footnote5
0152890001
| Active ingredient(s) | Strength |
|---|---|
| CLEVIDIPINE | 0.5 MG / ML |